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ABSTRACT 
 
Pulmonary aspergilloma is unprecedented disorder affecting lung 
parenchyma in already existing cavity in healed pulmonary tuberculosis 
patients. Typically, it is resulting from Aspergillus fumigates leading to 
development of fungal ball. Common presenting complaints are 
Haemoptysis, Dyspnoea, Cough, Chest pain and Fever. We are reporting 
a case of Pulmonary aspergilloma a sequel of Pulmonary tuberculosis, 
has been recognized on basis of clinical findings, chest X-ray, CT thorax 
in which Fungal ball is seen in pre-existing cavity. It has been managed 
with antifungal drug Amphotericin B and Itraconazole. It must be 
differentiated from different clinical entity specifically Lung carcinoma 
on basis of relevant examination and research to treat successfully.  
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INTRODUCTION 
Pulmonary aspergilloma is rare sickness because of 
Aspergillus Fumigatus which affects in pre-existing 
cavity of healed tuberculosis. It's usually seen in elder 
patients with history of smoking. And It is also common 
in the persons with immunocompromised status like 
Diabetes mellitus, Cystic fibrosis, HIV infected sufferers, 
prolonged Neutropenia [1, 2] here we are reporting this 
case to elicit various difficulties in diagnosing 
pulmonary aspergilloma with other mimicking disorder 
like Bronchogenic carcinoma because it additionally will 
be having cavity formation [1].  
CASE REPORT 
A seventy-eight years old male, came to hospital with 
complains of occasional cough with expectoration, 
Breathlessness, left sided chest pain and Haemoptysis 
for 4 days. And also, he gave history of pulmonary 
tuberculosis about 2 years back, which has been 
treated with 6 months routine of antitubercular therapy 
and recovered. On physical examination, we found out 
dull percussion notes and inspiratory crepitations on 
the left infra-clavicular region. Other systems have been 
unremarkable on examination. On investigations, in 
complete blood count, total count; 12750 cu mm, 
Haemoglobin; 10.6 gm/dl. His erythrocyte 
sedimentation rate (ESR) was 30 mm in first hour, 
creatinine was 1. 55 mg/dl Serum urea and Electrolytes, 
random blood sugar were within ordinary limits. Chest 
radiographs [Figure 1] and computerized tomographic 
scan (CT scan) of thorax [Figure 2] confirmed a cavitary 
lesion approximately 43x41 mm in length in upper lobe 
of the left lung with a mass inside it and a crescentic rim 
surrounding the mass suggestive of Fungal mass 
(mycetoma). And on sputum culture was showing as A 
Fumigatus. At the end, he was diagnosed to be as a 
case of Pulmonary Aspergilloma in healed tuberculous 
cavity with Ischaemic heart disease. We started out 
treatment with Intravenous Amphotericin B 10mg in 
500 ml Dextrose (7 days) and Oral Itraconazole for six 
months, he recovered satisfactorily. With follow up 
after 6 months patient became asymptomatic.  
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DISCUSSION 
Pulmonary aspergilloma is affected predominantly in 
male and usually found to be seen in healed pulmonary 
tuberculosis [3]. Aspergillus fumigatus is most common 
causative pathogen. however, many different species 
including A. flavus, A. niger, A. nidulans, A. terreus have 
additionally found to be causative pathogens. 
maximum of sufferers may be asymptomatic[3]. They 
will be presenting with cough, fever, haemoptysis [4] 
Fever is not common symptom. If present can be due to 
underlying bacterial infection[5,6]. On physical 
examination, there may be dull note on percussion, 
bronchial breath sounds at affected part[1]. On chest X 
ray and CT thorax indicates Pulmonary aspergilloma 
radiographically seems as a strong rounded mass, 
mobile, of water density, inside a spherical or ovoid 
cavity, and separated from the wall of the cavity by an 
airspace of variable size and shape in preexisting cavity 
as Fungal ball called air crescent sign[1,2,3]. On CT scan 
Differential diagnosis for mass in cavity are likely to be 
hydatid cyst and pulmonary abscess with necrosis[1]. 
Life threatening Haemoptysis is indicative of surgery, 
however associated technical difficulties secondary to 
Oblitered pleural space, indurated hilar structure, 
Failure of lung tissue to increase after operation, old 
age and as morbidity and mortality is higher aspect, 
Cavernotomy is indicated in symptomatic high risk 
patients who aren't suitable for lung resection [3,7]. 
Medical management includes intracavitary, 
endobronchial and parenteral route. Common drugs 
used are Amphotericin B and Itraconazole, Sodium 
potassium iodide, fluconazole [1,3]. Itraconazole orally 
powerful drug with lesser toxicity and excessive tissue 
penetration, effective doses of Itraconazole is 
commonly two hundred to four hundred mg/d orally 
with a duration of treatment of 6 to 18 months. [8] If 
oral therapy is inadequate, Itraconazole and 
amphotericin B injected percutaneously under CT 
guidance[9]. In our affected person, we had chosen 
Intravenous Amphotericin B for 7 days and oral 
Itraconazole for six months and patient responded to it.  
 
CONCLUSION  
Relevant medical examination and investigation are 
considered to distinguish pulmonary aspergilloma with 
other mimicking disorder for proper management. 
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